Bill Of Health

FEBRUARY 18, 2025

It provides tailored legal and regulatory support to patients, researchers, businesses, and incubators, driving progress in healthcare and biotechnology. Another main study in this key area involves the study of biotechnologies and so-called biosolutions. We recently published a study for the European Commission on these issues.

Life Sciences 52

Life Sciences Biotechnology Pharmaceuticals Regulations 52

HIT Consultant

OCTOBER 18, 2024

What You Should Know: – Phenomix Sciences , a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces a new partnership to advance precision medicine in obesity with InformedDNA, the nation’s leading applied genomics solutions company.

Integration 105

Integration Life Sciences Biotechnology Healthcare 105

HIT Consultant

JANUARY 14, 2022

Empowering Physicians & Life Science Companies. The outcome is curated Qdata™—disease-specific, fit-for-purpose data modules designed to help life sciences companies confidently drive business insights and rigorously inform research outcomes. Strategic Partners. Expansion Plans.

Life Sciences 98

Life Sciences Biotechnology Pharmaceuticals Population Health 98

HIT Consultant

NOVEMBER 18, 2021

Benchling , a San Francisco, CA-based life and sciences R&D cloud platform raises $100M in Series F funding at a $6B valuation, co-led by new investor Franklin Templeton and existing investor Altimeter Capital , and joined by new investors Tiger Global and Lone Pine Capital , as well as existing investors.

Biotechnology 97

Biotechnology Life Sciences Pharmaceuticals Accountability 97

HIT Consultant

MARCH 30, 2022

VivoSense will also use this financing to expand and refine its informatics platform for data analysis from wearable and connected technologies to deliver validated digital clinical outcome assessments (COAs) for life science research. Wearable Sensor Biomarkers that Advance Clinical Research.

Life Sciences 98

Life Sciences Biotechnology 98

HIT Consultant

JUNE 12, 2023

What You Should Know: Range Biotechnologies (Range Bio) announced $5.2M in seed funding, led by TechBio-focused ARTIS Ventures with participation from Pear VC , Page One Ventures , Civilization Ventures , Pillar , Four Cities Capital , Hawktail , and others.

Biotechnology 52

Biotechnology Prevention Life Sciences 52

HIT Consultant

JANUARY 29, 2025

What You Should Know: – OSE Immunotherapeutics SA, a biotechnology company focused on developing innovative immunotherapies, and Scienta Lab , a pioneer in AI-driven precision immunology is forming a strategic collaboration to leverage the power of artificial intelligence (AI) in the fight against inflammatory diseases.

Biotechnology 52

Biotechnology Life Sciences 52

HIT Consultant

DECEMBER 16, 2024

Yifat Merbls lab at the Weizmann Institute and published in Nature Biotechnology in 2023, allows high-throughput profiling of dozens of PTMs using mass spectrometry. At the core of Promise Bios success is its proprietary PROMISE (Protein Modification Integrated Search Engine) platform, developed by Co-Founder & CTO Dr. Assaf Kacen.

Biotechnology 52

Biotechnology Integration Life Sciences 52

Healthcare ECONOMIST

DECEMBER 26, 2023

Biotechnology companies (biotech) or small/medium-sized biopharmaceutical companies (SMEs) are most active in drug discovery, preclinical development and early-stage clinical development. About two-thirds comes from private sector life sciences companies. The paper also lists 7 different archetypes for drug development.

Biotechnology 115

Biotechnology Life Sciences Pharmaceuticals 115

HIT Consultant

OCTOBER 13, 2022

What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,

Biotechnology 98

Biotechnology Regulations Prevention Integration 98

HIT Consultant

AUGUST 26, 2024

OTCQB: HRGN) , a clinical-stage biotechnology company focused on developing organ regeneration technology for severe diseases, has secured approximately $5 million from a new investor through a private placement of shares. What You Should Know: – Harvard Apparatus Regenerative Technology, Inc.

Biotechnology 97

Biotechnology Life Sciences 97

HIT Consultant

AUGUST 13, 2024

This collaboration marks a significant step forward in the integration of AI and biotechnology for drug discovery and development. The company’s investment in Transcell further solidifies its position as a leader in the healthcare and life sciences industry.

Life Sciences 52

Life Sciences Biotechnology Integration Healthcare 52

GoMoHealth

DECEMBER 9, 2021

This has proven to modify behaviors of patients with chronic and complex conditions worldwide, resulting in significant improvement in health outcomes and adherence, and decreased costs of care for providers, hospitals, health plans, employers, and life science companies.

Biotechnology 100

Biotechnology Life Sciences Integration Hospitals 100

Bill Of Health

FEBRUARY 18, 2025

The Inter-CeBIL initiative fosters knowledge networks to address legal and ethical challenges in health and life science innovation. It provides tailored legal and regulatory support to patients, researchers, businesses, and incubators, driving progress in healthcare and biotechnology.

Life Sciences 52

Life Sciences Biotechnology Regulations Healthcare 52

HIT Consultant

APRIL 6, 2023

a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer and FDA approval to commence a clinical trial of the Biostage Esophageal Implant raises $6M from new and existing investors in a private placement of its shares of common stock. What You Should Know: Biostage, Inc.,

Biotechnology 98

Biotechnology Life Sciences 98

HIT Consultant

OCTOBER 14, 2022

Co-Founder, President, & CEO of Obatala Sciences, Inc. Trivia Frazier, Ph.D., – The funding will be used to further the commercialization of its first-of-kind research-enabling products and platform for drug discovery and development. Funding Accelerates Commercialisation of Research-Enabling Solutions.

Biotechnology 98

Biotechnology Pharmaceuticals Healthcare Innovation Prevention 98

Cloud Blogs

MAY 18, 2021

Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.

Biotechnology 90

Biotechnology Life Sciences Healthcare Innovation Healthcare 90

Bill Of Health

AUGUST 4, 2022

Not surprisingly, some representatives of the biotechnology industry, and many patent lawyers, reacted negatively to the decision, and have steadily lobbied Congress to restore patent protection for isolated and purified genomic sequences. Myriad Genetics (569 U.S. 576) the U.S.

Biotechnology 123

Biotechnology Life Sciences Pharmaceuticals Healthcare 123

HIT Consultant

OCTOBER 7, 2021

The firm is continuing to add new pharmaceutical and biotechnology companies to its client base, in new therapeutic areas, and has continued to expand with the addition of over 100 new employees so far in 2021.

Biotechnology 97

Biotechnology Pharmaceuticals Life Sciences 97

HIT Consultant

SEPTEMBER 29, 2023

What You Should Know: – Phenomix Sciences , a precision medicine biotechnology company that brings data-driven precision medicine to obesity treatment, announced it has been awarded the first patent related to its obesity phenotyping technology. – The patent (No.

Biotechnology 105

Biotechnology Life Sciences 105

HIT Consultant

OCTOBER 30, 2023

Miromatrix Background Miromatrix is a life sciences company focused on the development of bioengineered organs composed of human cells. United Therapeutics is a biotechnology company with six FDA-approved therapies to address rare, life-threatening conditions, and a pipeline that includes four ongoing registration-phase studies.

Life Sciences 52

Life Sciences Biotechnology Healthcare 52

HIT Consultant

DECEMBER 8, 2022

What You Should Know: – Vevo Therapeutics , an SF-based biotechnology company, launched today with a $12M seed round led by General Catalyst and Wing Venture Capital using its Mosaic in vivo drug discovery platform and next-generation AI models to uncover better drugs for more patients.

Biotechnology 97

Biotechnology Life Sciences 97

HIT Consultant

JUNE 19, 2024

Athos”), a clinical-stage biotechnology company, has chosen Vultr Cloud GPU to run its AI model training, tuning, and inference. What You Should Know: – Vultr , the world’s largest, privately-held cloud computing platform, today announced that Athos Therapeutics, Inc.

Biotechnology 111

Biotechnology Regulations Integration Hospitals 111

HIT Consultant

SEPTEMBER 21, 2022

a commercial-stage life sciences company dedicated to improving patient care through earlier detection of viral-driven cancers, recently announced a $33.4M Founded in 2017, Naveris is a privately held biotechnology company with facilities in Massachusetts and North Carolina. What You Should Know: – Naveris, Inc. ,

Biotechnology 52

Biotechnology Life Sciences 52

HIT Consultant

MAY 25, 2022

Pleno is based in San Diego’s Sorrento Mesa innovation hub proximate to a robust talent pool of experienced scientists, telecommunication engineers, and biotechnology innovators. The company currently employs 14 full-time employees and plans to rapidly grow its team in the coming months.

Biotechnology 98

Biotechnology Life Sciences 98

HIT Consultant

JANUARY 28, 2022

Benchling , pioneer of the R&D Cloud powering the biotechnology industry appoints Paul Robson, a cloud veteran as President of Field Operations and Elena Donio, the former CEO of Axiom and President of Concur, to its board, as a director and compensation committee chair. . – Leah Ray , Chief Customer Officer.

Biotechnology 98

Biotechnology Life Sciences Private Practices Pharmaceuticals 98

HIT Consultant

OCTOBER 9, 2024

What You Should Know: – clock.bio , a healthspan biotechnology company based at the Milner Therapeutics Institute in Cambridge, has secured $5.3M in seed funding to advance its groundbreaking research on human rejuvenation.

Biotechnology 97

Biotechnology Prevention Life Sciences 97

HIT Consultant

JULY 19, 2024

Jinyong Lee, CEO & Co-Founder of Kryptos Biotechnologies Most of us have been tested for COVID-19 over the past few years. If that’s true of you, you know the routine: you go to a testing site, give your sample, a medical professional sends it to a laboratory, and you receive your results in a day or two.

Biotechnology 98

Biotechnology Integration Life Sciences 98

HIT Consultant

JUNE 30, 2022

The new research reveals perspectives on the life sciences industry based on an extensive analysis of over 300 M&A deals made by the top 30 biopharma companies between 2010–2021. However, the pace of innovation in life sciences is at an all-time high. Inorganic Growth Strategy.

Life Sciences 52

Life Sciences Biotechnology Integration 52

HIT Consultant

SEPTEMBER 17, 2021

Benchling , pioneer of the R&D Cloud powering the biotechnology industry appoints Lindsey Irvine as Chief Marketing Officer. OptimizeRx , a provider of digital health solutions for life science companies, physicians and patients appoints Andrew D’Silva as senior vice president of corporate finance.

Biotechnology 98

Biotechnology Life Sciences Hospitals Telemedicine 98

HIT Consultant

SEPTEMBER 12, 2022

Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. In addition, the Sanderson Study will build the necessary infrastructure to bridge the gap between clinical research and day-to-day clinical impact.

Biotechnology 98

Biotechnology Prevention Health Data Hospitals 98

HIT Consultant

AUGUST 23, 2021

Novasenta is one of three local life science startups incubated by UPMC Enterprises in collaboration with Pitt over the last four years and is adding to a growing number of preclinical development programs this partnership is rapidly advancing. Novasenta’s recently hired chief executive officer and a veteran biotechnology leader.

Life Sciences 52

Life Sciences Biotechnology 52

Bill Of Health

DECEMBER 8, 2023

Attorney Gene Quinn offers the most dramatic interpretation, calling the Supreme Court’s embrace of full scope enablement in Amgen “a cataclysmic shift in the law of enablement,” not just for antibodies but for “the life sciences community and beyond.” Amgen’s significance has often been overstated. It was formally repealed in 2018.)

Biotechnology 52

Biotechnology Life Sciences Pharmaceuticals Regulations 52

HIT Consultant

JANUARY 26, 2025

In recent decades, advancements in biotechnology have made it possible to develop synthetic nuclei. .’ Here, each arm can bind to the specific antigen it is meant for and has a high affinity for. This binding helps eliminate the pathogens without harming the body’s cells.

Biotechnology 52

Biotechnology Prevention Life Sciences 52

HIT Consultant

AUGUST 27, 2024

By leveraging advanced biotechnology, ZBiotics enables consumers to actively engage in healthier living through probiotics engineered for specific use cases that solve real-world problems. ZBiotics is fundamentally driven by the mission to improve health through modern biotechnology. Led by a team of dedicated Ph.D.

Biotechnology 52

Biotechnology Life Sciences 52

HIT Consultant

JULY 19, 2023

To help tackle this inequality, gen-t and Omica.bio chose to partner with Lifebit – a leader in secure technology for biomedical research – to ensure the data they are collecting can be accessed, ethically and securely, for life sciences research. In Mexico, Omica.bio is leading a revolution in ethical biotechnology.

Biotechnology 52

Biotechnology Life Sciences Population Health Health Data 52

HIT Consultant

OCTOBER 3, 2023

Funding Focused on Disease Treatment, Value Based Care: Funding has shifted away from pandemic-related areas like on-demand healthcare and life science R&D catalysts, which were prominent in 2021 and 2022.

Biotechnology 59

Biotechnology Life Sciences Healthcare 59